Taichung Veterans General Hospital — Taichung, Taiwan

Public research footprint of Taichung Veterans General Hospital, compiled from the ClinicalTrials.gov public registry.

786

Registered studies

318

Active

176

Recruiting now

331

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Relapsed/Refractory Follicular Lymphoma · Metastatic Castration Sensitive Prostate Cancer (mCSPC)

Recently updated registry entries

NCT05663866 — Premedication to Reduce Amivantamab Associated Infusion Related Reactions (Active Not Recruiting)
NCT07581002 — A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV)… (Recruiting)
NCT03767244 — A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Taichung Veterans General Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.